Professional Documents
Culture Documents
Case Study 4 Drug Study
Case Study 4 Drug Study
After:
Observe for signs
and symptoms of
anaphylaxis (rash,
pruritus, laryngeal
edema, wheezing).
Monitor B/P
(standing, sitting,
supine).
Remind the client
to avoid tasks that
require alertness,
motor skills until
response to drug is
established.
Wash your hands
properly
Document the time,
location, dose,
medication given to
the patient.
DRUG STUDY 3
MEDICATION CLASSIFICATION/ INDICATIONS CONTRAINDICATIONS SIDE EFFECTS ADVERSE EFFECTS NURSING
ACTION RESPONSIBILITIES
Generic Name: Classification A single course of Untreated systemic Common side effects of Common adverse effects Before
Betamethasone Betamethasone is in a betamethasone is infections (oral, betamethasone are of betamethasone are Check and verify
class of medications recommended for parenteral); idiopathic follows: follows: doctor’s order
Brand Name: called corticosteroids; it pregnant women between thrombocytopenic purpura regarding the
Celestone usually uses to pregnancy 34 0/7 weeks and 36 6/7 (IM); perforated tympanic burning, itching, Significant: medication.
Celestone Soluspan, for maturity lung of the weeks of gestation at risk membrane (otic). irritation, stinging, Adrenal suppression (e.g. Observe 10 rights:
Betajec fetus. of preterm birth within 7 Ophthalmic: Bacterial, redness, or dryness suppression of Right patient, drug,
Betamethasone IM/PO. days, and who have not fungal, viral, tuberculous of the skin hypothalamic-pituitary- dose, time, and route.
Action received a previous or purulent eye infections; acne adrenal [HPA] axis, Make a medication
Usual Route: Betamethasone is a course of antenatal glaucoma, herpetic unwanted hair hypercortisolism, adrenal card with the
IM corticosteroid with corticosteroids keratitis (e.g. dendritic growth cortical atrophy); visual complete doctor’s
primarily glucocorticoid ulcer), undiagnosed red skin color changes disturbances (e.g. blurred order, name of the
Usual activity. It induces eye. Topical: Untreated bruising or shiny vision, glaucoma, posterior patient, bed number
Dosage/Frequency: phospholipase fungal, tubercular or subcapsular cataract,
skin and room/ward
0.6-7.2 mg orally divided A2 inhibitory proteins bacterial skin infections; central serous
tiny red bumps or Obtain and record
twice daily/four times daily (lipocortins) and viral skin lesions (e.g. rash around the chorioretinopathyleft vital signs.
or 0.6-9 mg/day sequentially inhibits the herpes simplex, varicella, ventricular free wall
mouth Secure a copy of the
intramuscularly each day release of arachidonic vaccinia), acne vulgaris, rupture. Rarely,
divided twice daily. small white or red client’s health history
acid, thereby depressing rosacea, perianal and anaphylactoid reactions. for contraindications
bumps on the skin
the formation, release, genital pruritus, perioral and drug interactions
Drug Order: and activity of dermatitis, pruritus without Gastrointestinal
betamethasone 12mg/IM (notify the physician if
prostaglandins, inflammation; infants <1 disorders: any).
Q 24 hrs x 2 doses histamines, and other year (betamethasone Abdominal distension,
Ask the client’s full
endogenous inflammatory valerate). Concomitant dyspepsia, nausea,
name to verify his
chemical mediators. administration with live oesophageal ulceration,
identity..
Pharmacokinetics: vaccines (in patients peptic ulcer with
Educate and explain
Absorption: Readily receiving perforation and
the medication to the
absorbed from the immunosuppressive haemorrhage; acute
client, how it works,
gastrointestinal tract (oral); doses). pancreatitis; taste
why it is given to him,
absorbed percutaneously disturbance (nasal).
and the possible side
(topical).
effects
Time to peak plasma General disorders and
concentration: 10-36 administration site
During:
minutes (IV). conditions:
Give daily dose
Distribution: Crosses the Malaise.
before 9 AM to mimic
placenta and enters breast
normal peak
milk.
corticosteroid blood
Plasma protein binding:
Metabolism and levels.
64%.
nutrition disorders: Increase dosage
Metabolism: Metabolised Hypokalaemic alkalosis, when patient is
primarily in the liver. impaired carbohydrate subject to stress.
Excretion: Via urine (<5% tolerance. Taper doses when
as unchanged drug). discontinuing high-
Elimination half-life: 6.5 Musculoskeletal and dose or long-term
hours. connective tissue therapy.
disorders: Do not give live virus
Osteoporosis, tendon vaccines with
rupture, vertebral and long immunosuppressive
bone fractures, avascular doses of
osteonecrosis. corticosteroids.
Examine area for
Nervous system infections and skin
disorders: integrity before
Headache. application.
Administer cautiously
Psychiatric disorders: to pregnant patients;
Irritability, mania, topical corticosteroids
delusions, hallucinations, have caused
behavioural disturbances, teratogenic effects
anxiety, sleep and can be absorbed
disturbances, confusion. from systemic site.
WARNING: Use
Reproductive system caution when
and breast disorders: occlusive dressings or
Menstrual irregularity, tight diapers cover
amenorrhoea. affected area; these
can increase systemic
Respiratory, thoracic absorption of the
and mediastinal drug.
disorders: Avoid prolonged use
Nasal irritation and near eyes, in genital
dryness, epistaxis, and rectal areas, and
rebound congestion, in skin creases.
bronchial asthma,
perforation or ulceration of
nasal septum, anosmia, After:
parosmia, sneezing.
Observe any signs of
Skin and subcutaneous side and adverse
tissue disorders: effect and notify the
Atrophy, bruising, acne, physician if any.
telangiectasia, striae, Monitor B/P
hypertrichosis, Stevens- (standing, sitting,
Johnson syndrome; supine).
pruritus, burning or
Remind the client to
stinging sensation, pain avoid tasks that
(topical). require alertness,
Vascular motor skills until
response to drug is
established.
Wash your hands
properly
Document the time,
location, dose,
medication given to
the patient
DRUG STUDY 3
MEDICATION CLASSIFICATION/ INDICATIONS CONTRAINDICATIONS SIDE EFFECTS ADVERSE EFFECTS NURSING
ACTION RESPONSIBILITIES
Generic Name: Classification: ferrous sulphate is as Ferrous sulfate is Most common side effect Most common adverse Before:
Ferrous Sulfate Belongs to the class of effective as twice daily contraindicated with of Ferrous sulfate are: reactions:
oral iron bivalent (130 mg elemental iron) Haemochromatosis ● feeling or being sick ● Check and verify
Brand name: preparations. Used in the dose regimen in , other iron (nausea or Gastrointestinal doctor’s order
Slow FE, treatment of anemia. prevention of Anaemia in overload vomiting), stomach disorders: regarding the
Fer-In-Sol pregnancy in a developing syndromes. pain or heartburn. Gastrointestinal medication.
Feratab, Iron Action: economy like Nigeria. Blood disorders ● loss of appetite. irritation ● Observe 10 rights:
Mol-Iron ferrous sulfate facilitates Once daily dose (e.g., paroxysmal Right patient, drug,
Feosol, oxygen transport via Hb. It possesses fewer side
● constipation. Nausea dose, time, and route.
nocturnal ● diarrhea.
MyKidz Iron 10. is used as iron source as it effects and guarantees haemoglobinuria,
Vomiting ● Make a medication
replaces iron found in Hb, better compliance in this ● dark or black poo. epigastric pain card with the
haemolytic
Usual Route: myoglobin and other study. ● black stained teeth complete doctor’s
anaemia, diarrhoea
Oral enzymes. haemosiderosis, (from the drops) order, name of the
Onset: Haematologic
constipation patient, bed number
other anaemias)
Usual dosage/Frequency response: Approx 3-10 blackening of stool and room/ward
active peptic ulcer
325 mg (65 mg of days (oral). Peak effect: tooth discolouration ● Obtain and record
regional enteritis
elemental iron) orally three Reticulocytosis: 5-10 abdominal vital signs.
and ulcerative
times a day, lower doses days; increased Hb: ● Secure a copy of the
colitis. discomfort.
(eg, 15-20 mg of Within 2-4 weeks. client’s health history
elemental iron daily) may Patient receiving
Pharmacokinetics: frequent blood Immune system for contraindications
be as effective and cause Absorption: Absorbed and drug interactions
transfusions. disorders:
fewer side effects. mainly in the duodenum (notify the physician if
Concomitant Hypersensitivity.
and upper jejunum. Food any).
Drug order: parenteral iron
and achlorhydria may ● Ask the client’s full
Ferrous Sulfate 1 capsule decrease absorption. therapy.
name to verify his
OD Distribution: Majority identity
binds to transferrin and ● Educate and explain
transported to the bone the medication to the
marrow. client, how it works,
Excretion: Via urine, why it is given to him,
sweat, sloughing of the and the possible side
intestinal mucosa, and effects
menses.
Half-life:
The half-life of orally
administered iron is not
readily available in the
literature, with total effects
During:
lasting 2-4 months
● Position patient
(congruent with the red
appropriately for
blood cell life span)11 with
medication
an onset of action of 4 administration
days and peak activity at ● Place at the bed side
7-10 days of the client
● Administer Ferrous
Sulfate tablet
● Give 1 cup of water to
the client after
administration
● Ensure proper body
mechanics for health
care provider
After:
● Be alert to neurologic
effects (headache,
lethargy, mental
confusion, agitation).
● Monitor B/P
(standing, sitting,
supine).
● Remind the client to
avoid tasks that
require alertness,
motor skills until
response to drug is
established.
● Wash your hands
properly
● Document the time,
location, dose,
medication given to
the patient